Standard
GLP-1 agonists for type 2 diabetes : pharmacokinetic and toxicological considerations. / Jespersen, Maria J; Knop, Filip K; Christensen, Mikkel.
I:
Expert Opinion on Drug Metabolism & Toxicology, Bind 9, Nr. 1, 2013, s. 17-29.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Jespersen, MJ
, Knop, FK & Christensen, M 2013, '
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations',
Expert Opinion on Drug Metabolism & Toxicology, bind 9, nr. 1, s. 17-29.
https://doi.org/10.1517/17425255.2013.731394APA
Jespersen, M. J.
, Knop, F. K., & Christensen, M. (2013).
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.
Expert Opinion on Drug Metabolism & Toxicology,
9(1), 17-29.
https://doi.org/10.1517/17425255.2013.731394Vancouver
Jespersen MJ
, Knop FK, Christensen M.
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.
Expert Opinion on Drug Metabolism & Toxicology. 2013;9(1):17-29.
https://doi.org/10.1517/17425255.2013.731394Author
Jespersen, Maria J ; Knop, Filip K ; Christensen, Mikkel. / GLP-1 agonists for type 2 diabetes : pharmacokinetic and toxicological considerations. I: Expert Opinion on Drug Metabolism & Toxicology. 2013 ; Bind 9, Nr. 1. s. 17-29.
Bibtex
@article{d1057bc64552487082cd830d55a0b35a,
title = "GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations",
author = "Jespersen, {Maria J} and Knop, {Filip K} and Mikkel Christensen",
year = "2013",
doi = "10.1517/17425255.2013.731394",
language = "English",
volume = "9",
pages = "17--29",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Taylor & Francis",
number = "1",
}
RIS
TY - JOUR
T1 - GLP-1 agonists for type 2 diabetes
T2 - pharmacokinetic and toxicological considerations
AU - Jespersen, Maria J
AU - Knop, Filip K
AU - Christensen, Mikkel
PY - 2013
Y1 - 2013
U2 - 10.1517/17425255.2013.731394
DO - 10.1517/17425255.2013.731394
M3 - Journal article
VL - 9
SP - 17
EP - 29
JO - Expert Opinion on Drug Metabolism and Toxicology
JF - Expert Opinion on Drug Metabolism and Toxicology
SN - 1742-5255
IS - 1
ER -
